Clinical investigation of medicinal products for the treatment of juvenile idiopathic arthritis

Current effective version

PDF iconRevision 2 - Adopted guideline

Reference numberEMA/CHMP/239770/2014 Rev. 2
Published20/11/2015
Effective from01/06/2016
KeywordsJuvenile idiopathic arthritis, systemic juvenile idiopatic arthritis, oligoarthritis, polyarthritis, enthesitis related arthritis, extrapolation
DescriptionThis document provides guidelines for the evaluation of medicinal products in juvenile idiopathic arthritis. It addresses specific issues related to the design of clinical studies, extrapolation of efficacy from other age groups and corresponding arthritis diagnoses, and assessment of disease activity.


Document history

Revision 2

Current version

PDF iconAdopted guideline


PDF iconOverview of comments


PDF iconDraft guideline


PDF iconConcept paper

In operation: 01/06/2016


Published: 27/11/2015


Published: 15/05/2014


Published: 28/09/2012

First version

PDF iconAdopted guideline


PDF iconOverview of comments


PDF iconDraft guideline

In operation: 01/05/2007–01/06/2016


Published: 30/04/2010


Published: 23/06/2005


Related content


How useful was this page?

Add your rating